US Bancorp

SEC CIK: 0000036104
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overview All 13F holders of AVTX Full Q2 2026 holdings

Shares (Q2 2026): 5,684
Value: $105.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of AVTX by US Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	5,684	$105.0K	<0.1%	+2,297+67.8%	Added	Holders
Q1 2026	3,387	$50.6K	<0.1%	+654+23.9%	Added	Holders
Q4 2025	2,733	$49.6K	<0.1%	+2,733	New	Holders